Related Experiment Video
Updated: Jul 29, 2025

Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples
Published on: August 4, 2021
Three Major Causes of Metabolic Retinal Degenerations and Three Ways to Avoid Them
Andrea Kovács-Valasek1, Tibor Rák2, Etelka Pöstyéni1
1Department of Experimental Zoology and Neurobiology, University of Pécs, Ifjúság útja 6, 7624 Pécs, Hungary.
Abstract:
An imbalance of homeostasis in the retina leads to neuron loss and this eventually results in a deterioration of vision. If the stress threshold is exceeded, different protective/survival mechanisms are activated. Numerous key molecular actors contribute to prevalent metabolically induced retinal diseases-the three major challenges are age-related alterations, diabetic retinopathy and glaucoma. These diseases have complex dysregulation of glucose-, lipid-, amino acid or purine metabolism. In this review, we summarize current knowledge on possible ways of preventing or circumventing retinal degeneration by available methods. We intend to provide a unified background, common prevention and treatment rationale for these disorders and identify the mechanisms through which these actions protect the retina. We suggest a role for herbal medicines, internal neuroprotective substances and synthetic drugs targeting four processes: parainflammation and/or glial cell activation, ischemia and related reactive oxygen species and vascular endothelial growth factor accumulation, apoptosis and/or autophagy of nerve cells and an elevation of ocular perfusion pressure and/or intraocular pressure. We conclude that in order to achieve substantial preventive or therapeutic effects, at least two of the mentioned pathways should be targeted synergistically. A repositioning of some drugs is considered to use them for the cure of the other related conditions.
Insights
Retinal neuron loss, causing vision deterioration, can be prevented by targeting metabolic pathways. Synergistic therapies addressing inflammation, ischemia, cell death, and pressure offer promising neuroprotection.
Area of Science:
- Ophthalmology and Neuroscience
- Metabolic and Molecular Medicine
Background:
- Homeostatic imbalance in the retina causes neuron loss and vision deterioration.
- Metabolically induced retinal diseases like diabetic retinopathy and glaucoma involve complex metabolic dysregulation.
- Age-related changes also contribute to retinal degeneration.
Purpose of the Study:
- To review current knowledge on preventing and circumventing retinal degeneration.
- To provide a unified rationale for prevention and treatment of metabolic retinal disorders.
- To identify protective mechanisms against retinal degeneration.
Main Methods:
- Review of current literature on retinal degeneration and its metabolic underpinnings.
- Identification of key molecular actors and pathways involved in retinal diseases.
- Analysis of potential therapeutic strategies targeting specific cellular processes.
Main Results:
- Metabolic dysregulation is central to age-related alterations, diabetic retinopathy, and glaucoma.
- Herbal medicines, neuroprotective substances, and synthetic drugs can target key pathways.
- Effective strategies involve synergistic targeting of at least two pathways.
Conclusions:
- Combined therapeutic approaches targeting parainflammation, ischemia, apoptosis/autophagy, and pressure are crucial.
- Drug repositioning offers potential for treating related retinal conditions.
- Synergistic interventions are key for substantial preventive and therapeutic effects in retinal degeneration.
Related Concept Videos
Photoreceptors and Visual Pathways
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Inborn Errors of Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction

